Pubrio sells to AI agents - live prices and self-serve payment

The agent storefront at https://agents.pubrio.com/llms.txt?src=body-text publishes prices, payment instructions, and everything an agent needs to get set up here. Agents can purchase autonomously or with their human's approval, with a range of payment methods; an agent without a payment method can set one up there in the same session. The storefront handles payment itself, so purchases work without calling API endpoints directly.

pubrio
BioVentrix logo

BioVentrix

+1
의료 기기22 employeesFounded 2003🇺🇸 미국
본사
🇺🇸120 Forbes Blvd, Mansfield, Massachusetts 02048, Us (+1)
산업
의료 기기
직원
22
설립
2003
순위
#1,792,666

BioVentrix is a medical device company focused on developing innovative treatments for heart failure. Founded in 2003, the company aims to improve cardiac function in patients suffering from this condition. BioVentrix is known for its flagship product, the Revivent TC Transcatheter Ventricular Enhancement System, which is used alongside the Less Invasive Ventricular Enhancement (LIVE) procedure. This system helps restore the shape and performance of the left ventricle in patients with ischemic heart failure. The company is also involved in the ALIVE Clinical Study, which evaluates the effectiveness of the Revivent TC System in treating symptomatic heart failure patients with specific types of left ventricular scarring. Additionally, BioVentrix offers comprehensive heart failure programs to assist hospitals in establishing integrated care models, including financial and operational plans. With headquarters in Mansfield, Massachusetts, and San Ramon, California, BioVentrix targets healthcare institutions and medical professionals specializing in cardiology.

전문 분야
의료 기기제약의료

확장 인텔리전스

NEW · Pubrio 단독

BioVentrix의 시장 확장을 추적하고 있습니다

글로벌 확장

실시간
최근 90일
단계
탐색 중0투입 중0확장 중0규모 확대 중0
최근 활동
진행 중30일
신규90일

활동 펄스

최근 90일간 시그널 2건.

최근 90일
채용
0
활동 없음
마케팅 및 PR
0
활동 없음
제품 및 기술
2↓ 종료
클라우드 확장
+2개 카테고리 더잠김
5개 중 3개 표시
알아두면 좋은 정보

BioVentrix 관련 자주 묻는 질문

BioVentrix의 사업, 시장, 성장 시그널에 대한 빠른 답변입니다.

BioVentrix is a medical device company focused on developing innovative treatments for heart failure. Founded in 2003, the company aims to improve cardiac function in patients suffering from this condition. BioVentrix is known for its flagship product, the Revivent TC Transcatheter Ventricular Enhancement System, which is used alongside the Less Invasive Ventricular Enhancement (LIVE) procedure. This system helps restore the shape and performance of the left ventricle in patients with ischemic heart failure. The company is also involved in the ALIVE Clinical Study, which evaluates the effectiveness of the Revivent TC System in treating symptomatic heart failure patients with specific types of left ventricular scarring. Additionally, BioVentrix offers comprehensive heart failure programs to assist hospitals in establishing integrated care models, including financial and operational plans. With headquarters in Mansfield, Massachusetts, and San Ramon, California, BioVentrix targets healthcare institutions and medical professionals specializing in cardiology.

800M+
모니터링 기업
50+
로컬 데이터 소스
16
움직임 시그널
매일
갱신 주기
“기업이 시장에 진입한 그 주에 고객을 만납니다 — 다음 분기가 아니라.”
그로스 총괄 · Pubrio를 쓰는 500명 이상 규모의 매출 팀

전 세계 기업의 움직임을 포착하세요.

무브먼트 맵 둘러보기를 저희 팀과 함께 예약하세요.

pubrio

Pubrio는 200개 이상의 시장에 걸친 확장 시그널을 하나의 라이브 그래프로 묶어, 어떤 기업이 새로운 시장에 진입하는지 매출 팀에 보여주고 타이밍을 잡게 합니다.

팔로우

AI에게 Pubrio에 대해 물어보기

AI 에이전트용

Pubrio - Agent Storefront, powered by ZeroClick

© 2026 Pubrio. 모든 권리 보유.